LNTH vs UNH

Lantheus Holdings is a profitable, well-managed company with a strong position in radiopharmaceutical diagnostics. However, achieving a 10x valuation ($54B) from its current $5.4B market cap within 3-5 years is an exceptionally high hurdle. The recently reported Q4 2025 earnings highlight a material deceleration: FY2026 revenue guidance implies a decline from FY2025, and flagship PYLARIFY sales dr...

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...